Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "B01AX" (11)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Defibrotide (B01AX01) 1 products
WHO-DDD
DrugBank.ca
IP
Defitelio 80 mg/ml
10
k.A.
Concentrate for infusion: Defibrotidum (Hergestellt aus Darmschleimhaut von Schweinen) 80 mg/ml
MEDA Pharmaceuticals
Switzerland GmbH
A
FB
G
Fondaparinux (B01AX05) 9 products
WHO-DDD
IP
CI
Arixtra 2.5 mg/0.5 ml
2 syringe(s)
11.40
28.80
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 2.5mg / 0.5ml
Viatris Pharma GmbH
●
B / SL
FB
G
IP
CI
Arixtra 2.5 mg/0.5 ml
10 syringe(s)
45.56
65.95
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 2.5mg / 0.5ml
Viatris Pharma GmbH
●
B / SL
FB
G
IP
CI
Arixtra 1.5 mg/0.3 ml
10 syringe(s)
19.76
37.90
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 1.5mg / 0.3ml
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Arixtra 5.0 mg/0.4 ml
10 syringe(s)
152.02
181.75
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 5mg / 0.4ml
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Arixtra 7.5 mg/0.6 ml
10 syringe(s)
152.02
181.75
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 7.5mg / 0.6ml
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Arixtra 10 mg/0.8 ml
10 syringe(s)
152.02
181.75
10 %
Injection solution in prefilled syringe: Fondaparinuxum Natricum 10mg / 0.8ml
Viatris Pharma GmbH
B / SL
FB
G
IP
CI
Arixtra 5.0 mg/0.4 ml
2 syringe(s)
38.00
60.00
k.A.
Injection solution in prefilled syringe: Fondaparinuxum Natricum 5mg / 0.4ml
Viatris Pharma GmbH
B
FB
G
IP
CI
Arixtra 7.5 mg/0.6 ml
2 syringe(s)
38.00
60.00
k.A.
Injection solution in prefilled syringe: Fondaparinuxum Natricum 7.5mg / 0.6ml
Viatris Pharma GmbH
B
FB
G
IP
CI
Arixtra 10 mg/0.8 ml
2 syringe(s)
38.00
60.00
k.A.
Injection solution in prefilled syringe: Fondaparinuxum Natricum 10mg / 0.8ml
Viatris Pharma GmbH
B
FB
G
Caplacizumab (B01AX07) 1 products
WHO-DDD
IP
CI
Cablivi 10mg
3681.63
4020.40
10 %
poudre et solvent pour solution injectable: Caplacizumabum 10 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
